Publisher
Purdue Pharma L.P.
2 published claims from Purdue Pharma L.P. appear in the database. The labels below compare each sampled claim with the record. They do not rate the publisher as a whole.
- Supported1
- Outdated1
Sampled claims
- Outdated94Purdue said in May 2023 that the Second Circuit had upheld its plan of reorganization, which included releases of opioid claims against members of the Sackler family.
- Supported83Purdue said in November 2025 that the bankruptcy court would confirm its new plan, which provides about US$7.4 billion in cash to creditors.
Reports and statements sampled
- Second Circuit Court Upholds Purdue Pharma’s Plan of Reorganization on AppealCompany statement, 30 May 2023
- Bankruptcy Court to Confirm Purdue Pharma’s Plan of ReorganizationCompany statement, 14 November 2025
Responses on record
- Purdue Pharma L.P., 14 November 2025, on this claim: Purdue said the plan achieved remarkable consensus with more than 99% creditor support.S4
Sources
- S4Tier B Bankruptcy Court to Confirm Purdue Pharma’s Plan of ReorganizationPurdue Pharma L.P. via Business Wire. Company statement. 14 November 2025.Company account of the court's indication of approval and the plan amounts. It is not the confirmation order.